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Nanofibrillated cellulose hydrogel 
Anionic nanofibrillated cellulose hydrogel 
A B S T R A C T   
Hydrogels, natural and synthetic origin, are actively studied for their use for implants and payload carriers. These 
biomaterials for delivery systems have enormous potential in basic biomedical research, drug development, and 
long-term delivery of biologics. Nanofibrillated cellulose (NFC) hydrogels, both natural and anionic (ANFC) ones, 
allow drug loading for immediate and controlled release via the slow drug dissolution of solid drug crystals into 
hydrogel and its subsequent release. This property makes NFC originated hydrogels an interesting non-toxic and 
non-human origin material as drug reservoir for long-term controlled release formulation or implant for patient 
care. A compelling tool for studying NFC hydrogels is Raman spectroscopy, which enables to resolve the chemical 
structures of different molecules in a high-water content like hydrogels, since Raman spectroscopy is insensitive 
to water molecules. That offers real time investigation of label-free drugs and their release in high-water-content 
media. Despite the huge potential of Raman spectroscopy in bio-pharmaceutical applications, the strong fluo-
rescence background of many drug samples masking the faint Raman signal has restricted the widespread use of 
it. In this study we used a Raman spectrometer capable of suppressing the unpleasant fluorescence background 
by combining a pulsed laser and time-resolved complementary metal-oxide-semiconductor (CMOS) single- 
photon avalanche diode (SPAD) line sensor for the label-free investigation of Metronidazole and Vitamin C 
diffusivities in ANFC. The results show the possibility to modulate the ANFC-based implants and drug delivery 
systems, when the release rate needs to be set to a desired value. More importantly, the now developed label free 
real-time method is universal and can be adapted to any hydrogel/drug combination for producing reliable drug 
diffusion coefficient data in complex and heterogeneous systems, where traditional sampling-based methods are 
cumbersome to use. The wide temporal range of the time-resolved CMOS SPAD sensors makes it possible to 
capture also the fluorescence decay of samples, giving rise to a combined time-resolved Raman and fluorescence 
spectroscopy, which provides additional information on the chemical, functional and structural changes in 
samples.   
1. Introduction 
Hydrogels are a promising class of materials both as implantable 
systems for tissue engineering, and as a basis for controlled drug release 
and delivery. In hydrogels, a network of inter-connected pores enables 
an efficient retention of water, and transport of oxygen, nutrients and 
waste products [1]. These implantable matrices should be biomaterials, 
which will provide mechanical support when used as implanted payload 
carriers. An ideal biomaterial for controlled drug delivery should mimic 
the ultrastructure and mechanical properties of native extra-cellular 
matrix (ECM) with the maintenance of biochemical and physical sig-
nals. In essence, the implanted delivery systems should be compatible in 
stiffness with the cellular environment that is identical to the native 
state of the particular cell type or tissue to be treated. Such optimized 
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biomaterials for delivery systems have enormous potential in basic 
biomedical research, drug development, and long-term delivery of 
biologics. 
Hydrogels from both synthetic and natural sources have been used 
for implants, and in addition different kinds of polysaccharides have 
been used as implants and payload carriers, but typically these require a 
separate cross-linking step to form a proper hydrogel network [2]. In 
contrast, the native nanofibrillated cellulose (NFC) produced in bacteria 
and plants [3] forms hydrogels composed of a network of cellulose 
nanofibers without additional chemical modifications. They have me-
chanically strong native crystalline structure, lateral dimensions in the 
nanometer length scale, and exhibit high aspect ratios [4]. NFC can be 
isolated from plant cell walls using intensive mechanical shearing 
combined with chemical and enzymatic pre-treatments, and the anionic 
NFC (ANFC) can be obtained via TEMPO oxidation [4–6]. In aqueous 
environment, the NFC and ANFC form hydrogels even at low concen-
trations, typically down to 0.1–0.2 wt% (Ref M4) enabling the control of 
loss (G’) and storage modulus (G") of the hydrogels and encourages their 
use as an implantable controlled delivery material. NFC hydrogels al-
lows drug loading for both immediate and controlled release via the 
slow drug dissolution of solid drug crystals into NFC and its subsequent 
release [6]. This property makes ANFC hydrogels an interesting non- 
toxic and non-human origin material as drug reservoir for long-term 
controlled release formulation or implant for patient care. Although 
the plant derived native nanofibrillar cellulose has not yet found ap-
plications in tissue engineering, its potential for wound healing appli-
cations has already been shown [7,8]. Critically, in order to produce and 
modulate the NFC and ANFC based drug delivery hydrogels, the diffu-
sivities of the payloads, i.e. drug molecules, nanoparticles, or vesicles, 
has to be known. Here, the label-free measurements for their charac-
terization would be extremely beneficial and needed. 
The importance of the transport properties of controlled-release in 
biological systems has been recently reviewed by A.C.Ribeiro and M.A. 
Esteso [9], who focused on understanding the physical chemistry of 
carrier-mediated transport phenomena in controlled drug release sys-
tems. They combined Raman spectroscopy with the analysis of pulse 
voltammetry, nuclear magnetic resonance (NMR), ultrasonic relaxation 
and dissolution kinetics. In addition, M.P.di Cagno et al. [10] recently 
used UV absorption detection in unstirred aqueous environment to 
measure the exact concentrations of the drugs and were successfully able 
to evaluate the drug diffusion coefficients. UV-based systems, however, 
lack the possibility to follow the stability of the drugs, since the UV- 
absorption is virtually always detected only in one wavelength, and 
even in the best of cases cannot reach the sensitivity of vibrational 
spectroscopy. 
Raman spectroscopy is a widely used method to resolve the chemical 
structure of different molecules especially in samples having a high- 
water content since Raman spectroscopy, is insensitive to water mole-
cules [11]. Therefore, it offers the possibility for label-free investigation 
of drugs and their release in high-water-content media. There are several 
studies presenting the use of Raman spectroscopy or confocal Raman 
microscopy for drug product analysis [12]. In these systems, the main 
aim is to have the spatial resolution of the excipients in drug products 
and the Raman analysis are performed in solid state. F.G.Vogt and M. 
Stromeir combined UV Raman microscopy analyses to diffuse reflec-
tance UV − visible and fluorescence spectroscopy with conventional 
bulk Raman spectroscopy [13]. Although all the studies were performed 
in solid state, their study highlights the need for the combination anal-
ysis of several spectroscopic methods. That was already suggested by S. 
Wartenwig and R.H.H. Neubert in 2005 at their review for the phar-
maceutical applications of Raman spectroscopy [14]. They suggested 
that the mid-IR and Raman spectroscopy are versatile tools in the field of 
bio- and pharmaceutics, with a wide field of applications ranging from 
characterization of drug formulations to elucidation of kinetic processes 
in drug delivery. Another example of the use of Raman spectroscopy in 
biomedical applications is the use of Raman imaging to detect the 
amount of hyaluronic acid increase of extracellular matrix deposition in 
human dermal fibroblasts [15]. The Raman imaging results indicated 
the macromolecule- and cell type- dependent effects on matrix assem-
bly, turnover, and stiffness in cell-derived matrices. 
Despite the huge potential of Raman spectroscopy in biomedical and 
pharmaceutical applications, there is a major issue that has restricted 
the widespread use of this powerful optical tool. The problem has been 
the strong fluorescence of many samples, including most drugs, that can 
mask the faint Raman signal [16]. An effective method to suppress the 
unpleasant fluorescence background is to use short pulsed lasers (~100 
ps) and time-gated detectors [17]. The time constant of fluorescence 
emission, which is typically in the scale of nanoseconds, is relatively 
long compared to the instantaneous process of Raman scattering. 
Therefore, by enabling the detector to collect photons only during the 
laser pulses, all the Raman scattered photons can be collected while 
simultaneously rejecting most of the fluorescence and other background 
photons from ambient light. Even though time-gating provides effective 
fluorescence and background suppression, the restricting challenge with 
time-gated devices has been their high complexity and costs. Tradi-
tionally, time-gated detectors have been implemented by means of 
techniques such as ultrafast time-gated intensified charge-coupled de-
vice cameras and optical Kerr gates coupled with detectors, which are 
sophisticated and bulky laboratory-only solutions [18,19]. To build a 
robust, compact and cost-effective fluorescence-suppressed Raman de-
vices, sensors utilizing time-gated single-photon avalanche diodes 
(SPADs) fabricated in standard high-voltage complementary metal- 
oxide-semiconductor (HVCMOS) process have been introduced to the 
field [20,21]. The high fluorescence rejection capability of time-gated 
CMOS SPAD-based Raman spectrometers have been already demon-
strated in the analysis of fluorescent pharmaceuticals [22,23]. 
The further development of the SPAD line sensors has led to more 
practical and compact time-resolved CMOS SPAD Raman sensors uti-
lizing the basic concept of time-correlated single-photon counting 
(TCSPC) procedure [19–21]. The CMOS technology enables the inte-
gration of all TCSPC electronics, such as delay units, time-to-digital 
converters (TDCs) and histograms, to the same application-specific in-
tegrated circuit with the SPAD line sensor itself, significantly reducing 
the overall complexity of the equipment compared to the more tradi-
tional TCSPC Raman devices based on either a SPAD or some other 
detector solution. A great advantage of time-resolved measurement over 
the conventional constant-size time-gating approach is that the width of 
the time gate, which is used to separate the Raman signal from the 
fluorescence tail, can be modified even in the data post-processing phase 
in order to obtain the best possible Raman signal-to-noise ratios. 
In this work, a Raman spectrometer based on a previously developed 
time-resolved CMOS SPAD line sensor [19] was utilized in the label-free 
investigations of Metronidazole and Vitamin C diffusivities as a function 
of ANFC hydrogel concentrations. The results are interesting for the 
modulation of ANFC-based implants and drug delivery systems, when 
the release rate needs to be set to a desired value. But more importantly, 
the method is universal and can be adapted to any hydrogel/drug 
combination for producing reliable drug diffusion coefficient data in 
complex and heterogeneous systems, where traditional sampling-based 
methods are cumbersome to use. The wide temporal range of the 
Fig. 1. Chemical structure of Metronidazole, MW 171.15 g/mol (left) and 
Vitamin C i.e. Ascorbic Acid, MW 176.12 g/mol (right). 
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employed time-resolved CMOS SPAD sensor makes it possible to capture 
also the fluorescence decay of samples, giving rise to a combined time- 
resolved Raman and fluorescence spectroscopy, which provides addi-
tional information on the chemical, functional and structural changes in 
samples [24]. 
2. Materials and methods 
The drug molecules Metronidazole and Vitamin C (Fig. 1) as dry 
powder were purchased from Merck (Sigma Aldrich, St Louis, USA) and 
0.9% ANFC hydrogel was purchased from UPM (GrowDex®-T, UPM 
Biomedicals, Helsinki, Finland). 0.9% ANFC hydrogel concentrations 
used were 0.9%, 0.45% and 0.225% diluted with the Milli-Q water. 
The time-resolved Raman spectrometer was an in-house built custom 
spectrometer, whose block diagram is shown in Fig. 2. It was built 
mainly using off-the-shelf optomechanical and optical elements from 
three major component vendors (Thorlabs, Edmund Optics and New-
port) and was designed to operate at 180-degree excitation and collec-
tion geometry. A 532 nm wavelength pulsed laser (TEEM photonics, 
France, model: ANG-500P-CHS) is used as an excitation source. The 
pulse width and repetition rate of the laser are 150 ps full width at half 
maximum (FWHM) and 300 kHz, respectively and the average optical 
power used was 208 mW. Most of the optical power is delivered to a 
sample through a microscope objective but a small fraction (~2%) is 
guided to the trigger detector to synchronize the time-resolving CMOS 
SPAD line sensor for measuring the time-of-arrival of backscattered 
photons from the sample. 
The time-resolved CMOS SPAD sensor was fabricated in 0.35 μm 
HVCMOS technology and consists of an 8 × 256 SPAD array and a 256- 
channel on-chip TDC with the temporal resolution of 20 ps. The tem-
poral range of the TDC was set here to 82 ns. The pitch of SPADs within 
the spectral axis is 41.6 um defining a wavenumber resolution of ~7 
cm− 1 and a wavenumber range of ~1800 cm− 1 for the whole Raman 
spectrometer. The data read-out procedure of the sensor currently limits 
the maximum frame rate of the system to 100 kframes/s and thus, the 
repetition rate of the laser cannot be fully utilized. 
The high temporal resolution and the wide temporal range of the 
sensor with simultaneous recording on all spectral points makes it 
possible to record 3-D data of collected photons from the sample (in-
tensity vs. time vs. wavenumber). Therefore, Raman and fluorescence 
photons can be separated in time-domain and ns-scale fluorescence 
lifetimes can be estimated by post-processing the recorded 3-D data. The 
post-processing of the data is done by using custom-made MATLAB 
scripts (MathWorks, USA) and includes, for example, the formation of 
the normal 2D (intensity vs wavenumber) Raman spectra with the 
desired time gate widths as well as the dark count and baseline correc-
tion and filtering of the formed spectra. A detailed description of the 
used time-resolved CMOS SPAD line sensor is given in reference [13]. 
Fig. 2. Block diagram of the time-resolved Raman and fluorescence spectrometer.  
Fig. 3. Schematic picture and photograph of the sample configuration, the reservoir and the pure ANFC had the same hydrogel concentration.  
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Drug diffusion and mass transfer measurements. The reservoir, con-
taining the ANFC and drug with the drug concentrations exceeding the 
aqueous drug solubility by ca. 5 times, was prepared at least 24 h prior 
the experiment, mixed vigorously and stored at +4C allowing the partial 
dissolution of the drug particle into the ANFC. 0.75 ml of ANFC con-
taining the drug was pipetted to the bottom of a 3.5 ml fused quartz 
cuvette (Thorlabs, USA, model: CV10Q3500F) and layered on top with 
2 ml of the pure ANFC having the same cellulose concentration as that of 
the reservoir (Fig. 3). The amount of the drug is high enough to assume 
that the reservoir maintains roughly the same drug concentration 
throughout and during the measurements since the total volume of 
ANFC (2.75 ml) is not enough to completely dissolve the drug. The 
prepared sample was then placed to a sample holder coupled with an 
XYZ translation state with standard micrometers (Thorlabs, USA, model: 
PT3/M) to enable accurate laser focusing. In total, two horizontal and 
three vertical laser focus locations, i.e. sampling points, were used in this 
study, as shown in Fig. 3. The lower sampling points were ~ 2.5 mm 
above the surface between the drug/ANFC dispersion and pure ANFC 
and the higher sampling points were 4 mm above the lower sampling 
points. 
The time-resolved Raman and fluorescence spectra from the different 
sampling points were always obtained in the same order (from the first 
acquisition point to the last): lower 1, lower 2, lower 3, higher 3, higher 
2 and higher 1 (numbering refers to Fig. 3). The Metronidazole samples 
were studied for 48 h and the Vitamin C ones for 120 h. Because the used 
spectrometer setup currently requires manually controlled data acqui-
sition, the measurements were conducted only during the daytime, 
accordingly; − day 1, 0–10 h; day 2, 23–30 h; day 3,46.5–48 h. The 
release was further monitored with Vitamin C samples by applying three 
additional sampling times at 72 h, 96 h and 120 h. The sampling interval 
during the days was 30 min and the spectra were recorded by shooting 
10 million laser pulses to the sample, resulting in an acquisition time of 
100 s per sampling point with the spectrum frame rate of ~100 kframes/ 
s. 
The Raman signal used in the diffusion coefficient calculations was 
derived from the time-gated Raman spectra obtained with 600 ps 
collection window achieved by summing up 30 adjacent time bins in the 
data post-processing phase. That enables the collection of all the Raman 
scattered photons generated by the laser pulses while at the same time 
rejecting major part of the fluorescence and other background radiation 
from ambient light. All the measurements were conducted in an open 
environment with regular laboratory lighting condition at room tem-
perature and atmosphere. Room temperature was maintained constant 
at 22 ◦C. The fluorescence lifetime was determined from the fluores-
cence decay curves at wavenumber areas where no Raman scattered 
signals and peaks were detected. 
The fluorescence lifetime analysis was only done with Vitamin C 
because Metronidazole does not have significant fluorescence. The 
fluorescence decay curves were formed by sweeping a 100 ps wide 
photon collection window through the time axis with steps of 20 ps 
(done in the data pots-processing phase) in order to achieve additional 
signal averaging. Furthermore, the fluorescence intensity was defined as 
the summed intensity of wavenumber range of 1852–2022 cm− 1, which 
presents the pure fluorescence without Raman. The fluorescence life-
times were estimated with the free DecayFit software [25], which uses 
iterative re-convolution with a least-squares analysis. The bi- 









fitted to the obtained decay curves, since this offered better fitting re-
sults than the single-exponential model. 
3. Theoretical section 
Fick’s second law in one dimension (Eqs. 1 and 2) was used to fit the 




∂x2 (1)  
∂f
∂x = 0, x = H = 2 cm, t > 0; f = 1, x = 0 cm, t > 0; f = 0, t = 0, x > 0;
(2)  
where D is the diffusion coefficient (cm2/s), f is the normalized con-
centration of the drug, t is the time (s), x the distance from the drug/ 
ANFC dispersion and initially empty ANFC solution, and H is the height 
of the empty ANFC phase. The concentrations are replaced here with f to 
represent the fraction of the drug concentration of the total aqueous 
solubility of the drug, i.e. a normalized concentrations (f = c/cS). The 
geometry in this case is non-standard as the diffusion is confined to a 
fixed length. As boundary conditions, c at the lower interface is kept 
constant at the solubility of the drug (cS) by the presence of dissolving 
drug powder, and the drug gradient at the top (x = H) is zero. 
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As the exact solution given by Eq. (3) is somewhat complex, an 
approximation of the diffusion coefficient can be obtained by first 
considering the case of semi-infinite diffusion, where the diffusion 
would not be confined to a fixed length H. The solution to Eq. (1) in this 







Eq. (4) can be expanded as Taylor’s series to yield even simpler 











It is good to remember that this equation only applies when there is 
no meaningful saturation occurring in the initially empty ANFC phase. It 





> x) but the concentration at the top is still quite 
close to zero. Regardless, this simplified solution can be useful for a 
quick estimation of diffusion coefficients, since with two horizontal 














where Δf is the difference in the normalized concentrations and Δh the 
height separation between the high and low sampling points. 
In practice, the estimated diffusion coefficients based on Eq. (7) need 
to be further adjusted by using the exact solution of Eq. (3) to account for 
possible non-linearities such as saturation during the experiments. 
However, there was a practical problem in using the correct solution, 
since when working with viscous hydrogels, it is very hard to fix the 
initial lower interface at an exact height. This means that even though 
Δh can be fixed, the exact values of x for the two measurement points are 
unknown. Fortunately, when two measurement heights are used, we 
have the additional benefit that the real locations can be estimated by 
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The final workflow for determining the diffusion coefficients in 
ANFC hydrogels can be found in Supporting Information together with 
the normalization of the data obtained. 
4. Results 
Before starting the analysis for diffusion constants of the studied 
drugs, the Raman spectra of ANFC in water, and Metronidazole and 
Vitamin C in solid form, in water and in 0.9% ANFC hydrogel-water 
were measured (Figs. 4 and 5). 
The vibrations assigned for Metronidazole and Vitamin C are shown 
in Tables 1 and 2. Raman peak amplitudes were used to estimate drug 
concentration used in the equations shown in the Theoretical section. In 
order to obtain the normalized concentrations (f), the Raman peak 
amplitudes at the different time points were divided by the ones of the 
saturated aqueous solution of the concerned drug. The used Raman peak 
amplitudes were the most relevant ones for taking into account the 
molecular structure for Metronidazole were at 1193 cm− 1, 1264 cm− 1, 
1370 cm− 1 and 1488 cm− 1, and the ones for Vitamin C were at 830 
cm− 1and 1692 cm− 1. 
One of the novelties of the present study is that the diffusion con-
stants can be calculated based on the Raman peak intensities, and the 
fluorescence decay time that was measured simultaneously, as shown in 
Fig. 6 (Vitamin C samples), can give extra information about e.g. drug- 
cellulose interactions. 
As can be seen based on the Tables 1 and 2 wavenumber and in-
tensity of the Raman peaks, some molecular level interactions may 
Fig. 4. The Raman spectra of Metronidazole in solid form (black), in water (red), and in 0.9% ANFC hydrogel-water solution (blue). (For interpretation of the 
references to colour in this figure legend, the reader is referred to the web version of this article.) 
Fig. 5. The Raman spectra of Vitamin C in solid form (black) in water (red) and in 0.9% ANFC hydrogel-water solution (blue). (For interpretation of the references to 
colour in this figure legend, the reader is referred to the web version of this article.) 
J. Zini et al.                                                                                                                                                                                                                                      
Journal of Controlled Release 334 (2021) 367–375
372
occur, but these seem to be very minor, as is the change in fluorescence 
decays in various ANFC samples (see Fig. 6). This indicates that direct 
chemical binding of the drug moieties to ANFC is weak and the expected 
changes in the diffusion coefficients are most likely dependent on the 
physical characteristics of ANFC, i.e. restriction of diffusion pathways 
due to the porosity and tortuosity of the cellulose network. Furthermore, 
the Raman spectra peaks were constant over time for both their position 
and relative intensities (Fig. 7), indicating that no drug degradation was 
taking place during the experiment. 
The diffusion constants of the drugs were calculated as explained 
above. The diffusion data measured with Raman along with the fitted 
values according to Eq. (3) are shown in Fig. 8 for Vitamin C and Fig. 9 
for Metronidazole. Table 3 lists the fitted diffusion coefficients. In the 
case of Metronidazole, the saturation of the top ANFC phase caused 
strong nonlinear effects on the concentration profiles and the exact so-
lution was needed for proper estimation of D. In the case of Vitamin C, 
the diffusion would have been possible to model also with the simpler 
Eq. (4), and estimate D with Eq. (7). It seems that there is no strong effect 
of ANFC concentration for the diffusivity of Vitamin C in this concen-
tration range, which is quite logical for a small hydrophilic drug. 
Moreover there seems to be no differences between the diffusion of Vit C 
in ANFC and water, this observation have been reported in other studies 
where is suggested that ANFC hydrogels affect the drug diffusion at 
concentration higher than 3% [26]. There seems to be a stronger cor-
relation between the diffusion coefficient and ANFC concentration in the 
case of metronidazole. Metronidazole seems to defuse faster in lower 
concentration of ANFC then in higher concentrated ANFC or water 
which would indicate that the important characteristic for mass trans-
port in nanofibrillar cellulose would be the hydrophobicity of the drug 
[27]. The lack of a strong correlation between hydrogel concertation 
and diffusion speed might be due to the heterogeneous pore size of the 
ANFC, which display a pore size distribution between ~1 to 100 μm 
[28], however, more thorough understanding of the underlying factors, 
a large screening study might be needed. 
5. Discussions 
Based on the presented results above, we were able to show, that it is 
possible to follow the drug diffusion and mass transfer in an unstirred 
hydrogel environment by on-line, label-free, fluorescence- and 
background-suppressed Raman spectra, and simultaneously obtain the 
information of the fluorescence decay times. Drug diffusivities were 
evaluated for the first time in unstirred hydrogels on-line by following 
the amplitude of the Raman peaks of the studied drugs, while simulta-
neously evaluated drug fluorescence decays were used to verify possible 
binding or drug degradation was taking place. It is not the first time that 
a spectroscopic technique is used for diffusivity studies [10,32], how-
ever in the previous study, UV–vis spectroscopy was chosen. The phe-
nomena behind UV spectroscopy are the absorption and emission of the 
UV light which has a wavelength (λ) from 200 nm to 700 nm. The ab-
sorption and the emission depend on chemical nature of the analyte. 
Therefore, the energy difference between the electronically excited ab-
sorption and emission is dissipated into the radiation less intersystem 
crossing from the electronically excited states to the first electronically 
excited state and its lowest vibrational state. That radiation less 
Fig. 6. Fluorescence decay curves with the different ANFC concentrations formed by taking the average of the time points 24 h, 48 h and 120 h (solid lines). Dotted 
lines present the bi-exponential fitting curves, whose equations are shown in the top-right corner. 
Table 1 








746 (w)   CH2 rock 
837 (w) 837 (w) 832(w) Ring breathing 
865 (vw)   CH3 rock, sigma 
CH2 
910 (vw)   Gamma CH2, CH2 
rocking 
951 (vw)   sigma OH 
1077 (vw)   CH 
1160 (sh)   C-C, CH 
1186 (s) 1193 (s) 1193 (s) v C-N 
1264 (m) 1272 (m) 1272 (m) N-O 
1356(m) 1370 (s) 1370 (s) v C–N aromatic 
1377 (m) 1392(sh) 1392(sh) CH2 scissor, sigma 
CH3 
1481 (m) 1488 (m) 1488 (m) C¼O, sigma 
asymmetric CH3 
1529 (m) 1536 (w) 1536 (w) C=C 
vw = very weak; w = weak, m = medium, s = strong. 
Table 2 
Assignment of vitamin C vibrations as Raman shifts (cm− 1).  
Vitamin C in solid 
state 





642 (s) 642 (vw) 642 (vw) OH out-of-plane 
deformation 
C–C ring stretching 
718 (w) 702 (vw) 702 (vw) OH out-of-plane 
deformation 
830 (s) 830 (s) 830 (m) C-C ring stretching 
1028 (w) 1050 (w) 1050 (w) C-O-H bending, C-O-C 
stretching 
1129 (s) 1151 (vw) 1151 (vw) C-O-C stretching 
1257 (m) – – C-O-H bending (twisting) 
1321 (m) 1349 (vW) 1349 (vw) CH bending (wagging) 
1453 (vw) 1467 (vw) 1467 (8vw) CH bending 
1665 (s) 1692 (s) 1692 (s) C¼C ring stretching 
vw = very weak; w = weak, m = medium, s = strong. 
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intersystem crossing may heat the sample, and therefore may also affect 
its diffusion coefficient. Moreover, in UV–vis spectroscopy the absorp-
tion intensity to calculate the diffusion is at the most cases detected only 
in one wavelength, thus it cannot provide exhaustive information on the 
drug nor its environment. The Raman spectroscopy is based on the in-
elastic scattering of light, which is an event that occurs at the lower 
energy compared to the UV–vis absorption. Raman spectra are able to 
reveal the chemical nature of the samples, as well its physical status, 
while the fluorescence lifetime changes in its environment. However, in 
our case, the effect of the ANFC hydrogel concentration on the fluores-
cence decay was practically negligible. 
Raman technology has progressed strongly during the last twenty 
years for applications in the biomedical field. Crucially, it offers a so-
lution to one of the biggest problems in drug analytics, intrinsic drug 
fluorescence, which can be avoided by using the time-gated Raman 
technology. That has now also been shown in the case of the Raman 
analysis of the EVs [22] and could be applied in the future for other 
Raman analysis of biomolecules. Equally importantly, it is unaffected by 
the presence of water and is not measured in transmission mode. This 
uniquely makes it suitable for drug analytics in heterogeneous hydro-
gels, which intrinsically have high water contents and efficiently scatter 
incoming light. The possibility to simultaneously detect the fluorescence 
intensity and decay times reveals yet another important parameter to 
monitor concerning the drug release. The decay times are sensitive to 
changes in the environment of the drugs, while the intensity makes it 
possible to directly monitor the release of fluorescent drugs and bio-
molecules. All these measurements were shown to be possible to 
perform on-line and label-free. 
Raman spectroscopy is known to be sensitive to molecular level 
changes [23]. Therefore, the developed system can also be utilized to 
Fig. 7. The combined 3D time-resolved Raman and fluorescence spectra of Vitamin C measured after 5 h, 24 h, 48 h and 120 h in 0.9% anionic nanofibrillated 
cellulose (ANFC) hydrogel (left side figures). Right side figures show the post-processed time-gated Raman spectra with the time gate width of 600 ps. The data was 
collected from the lower sampling point 2. 
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Fig. 8. A, B, C: Vitamin C normalized concentrations in ANFC vs. time. The ANFC concentration was either 0.9% (A), 0.45% (B), or 0.225% (C). Symbols show 
measured values based on Raman measurements and lines show theoretical values obtained by the from Eq. (3). Blue symbols/lines are from the lower measurement 
position, while red symbols/lines are from the higher measurement position. D: Simulated concentration vs. height profile at different time points for measurements 
done in 0.225% ANFC. The dashed line shows what the results of a semi-infinite solution would look like. The “reflected” curve shows the difference to the exact 
solution. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
Fig. 9. A, B: Metronidazole normalized concentrations in ANFC vs. time. The ANF concentration was either 0.225% (A) or 0.45% (B). Symbols show measured values 
based on Raman measurements and lines show theoretical values from eq. Blue symbols/lines are from the lower measurement position, while red symbols/lines are 
from the higher measurement position. C: Simulated concentration vs. height profile at different time points for measurements done in 0.225% ANFC. The dashed 
line shows what the results of a semi-infinite solution would look like. The “reflected” curve shows the difference to the exact solution. (For interpretation of the 
references to colour in this figure legend, the reader is referred to the web version of this article.) 
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follow the drug stability during drug release studies and the long-term 
stability of the drugs in hydrogels. The method could be further 
extended to the study of e.g. the diffusion of biomedical proteins in 
hydrogels, and detect their short- and long-term stabilities and dena-
turation rates, which cannot be otherwise easily evaluated on-line. This 
would also be of great value for the automatization of the manufacturing 
process of controlled release systems and implants, for example. Based 
on the findings, it would be then easy to adjust the formulation pa-
rameters such as thickness, drug loading, or cellulose content and 
modulate the drug release rate to be relevant in terms of the pharma-
cokinetics of the drug. 
6. Conclusion 
Our study shows that detailed and comprehensive information about 
drug diffusion kinetics in ANFC can be obtained with a simple experi-
mental set-up. Our study also highlights the power of the combined real 
time label-free time-resolved Raman and fluorescence/fluorescence 
lifetime analysis for drug release analytics to be applied into the field of 
bio- and pharmaceuticals enabling the real time label-free analysis of the 
payloads also in pharmaceutical hydrogels for further applications in the 
field. 
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Table 3 
Diffusion coefficients of Vitamin C and Metronidazole in various ANFC con-
centrations based on Raman measurements and theoretical fitting, and the 
values fin water found at the literature.   
D in 0.225% 
ANFC  
(x10− 6 cm2/ 
s) 
D in 0.45% 
ANFC  
(x10− 6 cm2/ 
s) 




D in water 
(x10− 6 cm2/s) 
Vitamin c 5.0 6.0 4.8 5.32 ± 0.26[29] 
6.8 ± 0.6[30] 
Metronidazole 15 10 N.d. 4.3[31]  
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